No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US OptionsDetailed Quotes
HTLD240719C12500
- 0.16
- 0.000.00%
15min DelayTrading Jun 26 10:19 ET
0.00High0.00Low
0.00Open0.16Pre Close0 Volume41 Open Interest12.50Strike Price0.00Turnover0.00%IV-1.02%PremiumJul 19, 2024Expiry Date0.29Intrinsic Value100Multiplier3DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma79.94Leverage Ratio--Theta--Rho--Eff Leverage--Vega
Intraday
- 5D
- Daily
News
Barclays Maintains Heartland Express(HTLD.US) With Sell Rating, Cuts Target Price to $10
Barclays analyst Brandon Oglenski maintains $Heartland Express(HTLD.US)$ with a sell rating, and adjusts the target price from $11 to $10.According to TipRanks data, the analyst has a success rate
Heartland Express Cut to Neutral From Buy by UBS
Heartland Express Cut to Neutral From Buy by
Why Helen of Troy Shares Are Trading Lower By Around 30%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Shares of Helen of Troy Limited (NASDAQ:HELE) fell sharply during Tuesday's session after the company reported soft first-quarter earnings and lowered its FY25 guidance.Helen of Troy reported
Express News | Heartland Express Inc : JP Morgan Cuts Target Price to $10 From $12
Express News | Heartland Express Inc : JP Morgan Cuts to Underweight From Neutral
Express News | Heartland Express Inc : UBS Cuts to Neutral From Buy; Cuts Target Price to $13 From $15
Comments
Analysts turn bearish after recent results, leading to reduced revenue forecasts and a significant cut in EPS estimates. Despite forecast cuts, the price target remains unchanged, implying the changes don't significantly impact intrinsic value. The company's revenues are expected to underperform the wider industry.
Heartland Express, Inc. Just Recorded A 372% EPS Beat: Here's What Analysts Are Forecasting NextThe future decline in revenue growth is worrisome despite the company's strong past performance. The P/S ratio, similar to the industry average, indicates possibly unsustainable current price levels considering the bleak revenue outlook.
Insider purchases show confidence in Heartland Express's future, implying a correlation between insiders and other shareholders. The high price for earlier shares indicates insiders saw value even at a premium.
The recent insider purchases suggest a positive outlook and strong confidence about the future of Heartland Express, Inc. The significant level of insider ownership indicates that the management's interest aligns with that of the shareholders.
Upgrades
• $Ascendis Pharma A/S(ASND.US$: BofA Securities Upgrades to Buy from Neutral - PT $161 (from $148)
• $GoodRx(GDRX.US$: Baird Upgrades to Outperform from Neutral - PT $17
• $W.W. Grainger(GWW.US$: Atlantic Equities Upgrades to Overweight from Neutral - PT $580 (from $520)
• $Heartland Express(HTLD.US$: Morgan Stanley Upgrades to Equalweight from Underweight - PT $16
• $The Mosaic(MOS.US$: Goldman Sachs Upgrades to Buy from Neutral - PT $83
• $Northern Oil & Gas(NOG.US$: Johnson ...
• $Ascendis Pharma A/S(ASND.US$: BofA Securities Upgrades to Buy from Neutral - PT $161 (from $148)
• $GoodRx(GDRX.US$: Baird Upgrades to Outperform from Neutral - PT $17
• $W.W. Grainger(GWW.US$: Atlantic Equities Upgrades to Overweight from Neutral - PT $580 (from $520)
• $Heartland Express(HTLD.US$: Morgan Stanley Upgrades to Equalweight from Underweight - PT $16
• $The Mosaic(MOS.US$: Goldman Sachs Upgrades to Buy from Neutral - PT $83
• $Northern Oil & Gas(NOG.US$: Johnson ...
5
Read more